newsfilter
← Latest News
Business Wire·

PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab

Results presented on April 2nd during a Late Breaking Featured Clinical Research Presentation at the American College of Cardiology's 71st Annual Scientific Session (ACC.22) Trial achieved primary reversal endpoint in older volunteers Bentracimab